CNO officer plans $216K stock sale, 3,919 shares
An officer of CNO Financial Group filed a Form 144 to sell 3,919 shares of CNO common stock acquired through equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CNO Financial Group, Inc. (CNO) is the issuer of common stock for which officer Jeanne Lynn Linnenbringer has filed a notice of proposed sales under Rule 144. The filing covers 3,919 shares to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an estimated aggregate sale price of $215,979.62 as of September 2, 2026. The securities were acquired upon vesting of restricted stock and Performance Shares during the period from March 25, 2021 through March 25, 2025, and follow recent sales in the prior three months.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CNO’s latest Form 144 filing disclose?
What CNO (CNO) sales has this person made in the past three months?
Which broker is handling the proposed CNO (CNO) Form 144 sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.